Tumour markers for prostate cancer
Tumour markers for prostate cancer. Prostate cancer is the third most common cancer
in men world-wide. The number of patients diagnosed has greatly increased, in large part due to more accessible diagnostic techniques as exemplified by the tumour marker Prostate Specific Antigen [PSA]. PSA enables detection of even relatively small tumours, but does not provide any information on the aggressiveness of the tumour.Several publications have concluded that combining PSA with Tissue Polypeptide Specific antigen [TPS], a marker measuring disease activity, yields vital information for correct and efficient patient
management, particularly in patients presenting
with metastatic prostate cancer.
Read more about Tumour markers for prostate cancer Tumour markers for prostate cancer
IDL Biotech AB
